What is resection of a cystic pancreatic tumor?
Cystic pancreatic tumors are a group of lesions that may be benign, precancerous, or malignant.
They include:
- intraductal papillary mucinous neoplasm (IPMN)
- mucinous cystic neoplasm (MCN)
- serous cystadenoma
- solid pseudopapillary neoplasm (SPN)
- other rare cystic lesions
Depending on the location of the tumor, the following may be performed:
- enucleation
- central pancreatectomy
- distal pancreatectomy
- pancreaticoduodenectomy
- total pancreatectomy
Our approach
At MSI, cystic tumors are treated in line with modern guidelines from the *NCCN, ESMO, IAP (International Association of Pancreatology), and the European evidence-based guidelines*.
Before surgery, every patient undergoes a comprehensive examination, which may include:
- multiphase computed tomography
- MRI with MRCP
- endoscopic ultrasound (EUS)
- cyst aspiration with fluid analysis, when indicated
- laboratory tests and tumor markers
The goal of treatment is complete removal of the tumor while preserving as much pancreatic function as possible.
*When technically feasible and oncologically safe, we aim to perform operations laparoscopically.* The extent of resection is determined individually, depending on the location and morphology of the lesion.
Postoperative treatment follows the principles of *ERAS (Enhanced Recovery After Surgery)*.
When is surgery needed?
Surgical treatment is recommended for:
- mucinous cystic neoplasm (MCN)
- IPMN with high-risk features
- solid pseudopapillary neoplasm (SPN)
- symptomatic serous cystadenomas
- growth of the cystic lesion
- suspected malignant transformation
Indications for surgery
Surgery is recommended for:
- a high risk of malignancy
- the presence of "high-risk stigmata" or "worrisome features" according to international guidelines
- symptomatic lesions
- rapid tumor growth
- cases where malignancy cannot be ruled out
How is the operation performed?
The procedure is performed under general anesthesia.
The type of operation depends on the location of the tumor:
- for tumors of the head — pancreaticoduodenectomy
- for tumors of the body or tail — distal pancreatectomy
- for certain benign lesions — central pancreatectomy or enucleation
For malignant lesions, a regional lymph node dissection is also performed.
The removed specimen is sent for full histopathological examination.
Advantages of laparoscopic surgery
- Performed laparoscopically whenever possible
- Less surgical trauma
- Less postoperative pain
- Faster recovery
- Lower risk of postoperative complications
- Shorter hospital stay
- Maximum possible preservation of pancreatic function
Recovery after surgery
Postoperative treatment follows *ERAS* principles.
The length of recovery depends on the extent of the procedure. After organ-preserving operations, patients return to their normal lifestyle faster. After major resections, enzyme therapy is prescribed if necessary, and blood glucose is monitored.
Our advantages
- Specialization in the treatment of pancreatic tumors
- Individual choice of the optimal extent of surgery
- Maximum possible preservation of organ function
- A commitment to laparoscopic surgery
- Adherence to NCCN, ESMO, and IAP international guidelines
- A multidisciplinary approach
- Enhanced recovery program (ERAS)
Frequently Asked Questions
No. Many cystic lesions only need monitoring. Surgery is recommended when there is a high risk of malignant transformation, when symptoms appear, or when the lesion grows.
It depends on the location, type, and size of the tumor. We always choose the smallest possible extent of surgery that ensures complete and safe removal of the lesion.
Yes. When indicated and oncologically safe, we aim to perform the resection laparoscopically.
In most cases, no. Total pancreatectomy is performed only under very limited indications.
Yes. Some types of cystic lesions, in particular *IPMN and MCN*, carry a risk of malignant transformation and therefore require regular monitoring or timely surgical treatment.